What is CVE-2023-47254?

CVE-2023-47254 is a critical-severity vulnerability in Draytek Vigor167, classified under OS Command Injection. CVSS score: 9.8/10. Published 2023-12-09.

How severe is CVE-2023-47254?

Critical severity. CVSS v3 base score is 9.8 out of 10.

Is CVE-2023-47254 known to be exploited?

1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

RCE in Draytek Vigor167

CVE-2023-47254

An OS Command Injection in the CLI interface on DrayTek Vigor167 version 5.2.2, allows remote attackers to execute arbitrary system commands and escalate privileges via any account created within the web interface.

Vulnerability class: Command Injection (OS Command Injection)

EPSS: 0.022 (80.7th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

Affected products

Draytek Vigor167
Draytek Vigor167_firmware — versions 5.2.2
N/a — versions n/a

Weakness classification (CWE)

CWE-78 — OS Command Injection

Public proof-of-concept exploits

fkie-cad/nvd-json-data-feeds

References

cve@mitre.org (Exploit, Third Party Advisory)
cve@mitre.org (Third Party Advisory)

Frequently asked questions

What is CVE-2023-47254?: CVE-2023-47254 is a critical-severity vulnerability in Draytek Vigor167, classified under OS Command Injection. CVSS score: 9.8/10. Published 2023-12-09.
How severe is CVE-2023-47254?: Critical severity. CVSS v3 base score is 9.8 out of 10.
Is CVE-2023-47254 known to be exploited?: 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.